Zoetis

Six S&P 500 stocks often experience a surge when shares of Nvidia Corporation (NASDAQ:NVDA) take a dip, an analysis by CNBC revealed. What Happened: The six U.S.-listed stocks that typically see a rise when Nvidia’s shares falter include Jack Daniel's distiller Brown-Forman Corporation (...

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among the insiders making purchases this week. Biotechs, REITs and a car rental leader saw notable insider purchasing of shares. Conventional...

This weekend's Barron's suggests ways to play U.S.-China tensions and the stock-splitting trend. Other featured articles look at how the election could affect health care stocks and what to expect from big-box retail earnings. Also, the prospects for a pharmaceutical giant, regional bank...

This weekend's Barron's cover story offers a head-to-head matchup of the two leading U.S. telecoms. Other featured articles examine prospects for an industrial giant undergoing a colossal restructuring and a big bank making a clean break Also, how to play animal health and a low-key...

This weekend's Barron's examines whether the country's largest bricks-and-mortar bookseller is down and out. The prospects for the world's largest animal-health company and a good contrarian stockpicker are also examined. This week's cover story finds dissension in...

U.S. stocks were little changed on Wednesday in another quiet trading session due to a lack of catalysts to move stocks. Economic data showed wholesale inventories rose more than expected in September. Looking forward to Thursday, retail giant Wal-Mart will report earnings before market open...

U.S. markets were little changed at the end of the trading day. The bond market was closed on Tuesday to commemorate Veterans Day. Typically speaking, the bond market is a major driver of the equities market. When the bond market is closed, equities volume tends to be lower in a less volatile...

Leading generic drug maker Teva Pharmaceutical (NYSE: TEVA) posted better than expected earnings last week and raised its full-year profit forecast. There was plenty for investors to be concerned about, though. Sales of its best-selling product, Copaxone, were down for the quarter, and activist...

This weekend in Barron's online: how to play the merger boom, as well as the prospects for Time Inc., Global Brass & Copper, Barnes & Noble and more. Cover Story "Top 10 Ways to Play M&A" by Jack Hough. Mergers are at near-record levels, says this week's cover story in Barron's, and...

This weekend in Barron's online: a more sophisticated strategy for investing in emerging markets, an ETF special report, and the prospects for The Pantry and Globe Specialty Metals. Cover Story "Emerging Markets: The Next Wave" by Reshma Kapadia. A more complicated global economy calls for a...